
    
      The treatment with vorinostat will be administered daily over 28 days. This period will be
      referred to as a therapy cycle. Two consecutive therapy cycles will be separated by a 7-days
      therapy break. In case of a good response and no relevant side effects, the treatment with
      vorinostat can be continued for up to 1 year after begin of the treatment. If any relevant
      side effects or intolerability occur, the dose and/or schedule of administration will be
      modified according to the pre-defined criteria.
    
  